Physician profile
Winston Fong
NPI 1548478696
$758,367.34
in general payments reported to CMS, 2019-2025
20 companies · $253K in 2025
The $253K reported for 2025 was more than what 97% of Orthopaedic Surgery of The Spine providers received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $36K · 2020: $32K · 2021: $2,665 · 2022: $94K · 2023: $150K · 2024: $192K · 2025: $253K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $500K · Consulting Fee: $77K · Travel and Lodging: $15K · Food and Beverage: $1,888.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $500,014.07 |
| Consulting Fee | $77,475.45 |
| Travel and Lodging | $15,134.25 |
| Food and Beverage | $1,887.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alphatec Spine, INC | $711,119.58 | 2019-2025 | Identiti, Other - Miscellaneous, Safeop |
| Aurora Spine, INC. | $33,572.16 | 2019-2020 | |
| Nanohive Medical LLC | $7,534.81 | 2019 | |
| Evolution Spine, LLC | $2,000.00 | 2019 | |
| Corelink, LLC | $1,875.00 | 2019 | |
| Si-Bone, INC. | $688.98 | 2019-2022 | |
| Arthrex, INC. | $387.86 | 2024-2025 | |
| Pylant Medical | $368.81 | 2024-2025 | |
| Spineology INC. | $206.82 | 2024 | Optimesh Expandable Interbody Fusion System |
| Globus Medical, INC. | $140.14 | 2025 | Vyrsa V1 |
| Stryker Corporation | $137.63 | 2019 | |
| Boston Scientific Corporation | $83.85 | 2023-2024 | Wavewriter Alpha Prime 16 |
| Nevro Corp. | $65.93 | 2019-2024 | Senza |
| Ucb, INC. | $58.56 | 2022-2023 | Cimzia |
| Ethicon US, LLC | $32.87 | 2023 | Enseal |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Innovation Technologies INC | $24.88 | 2024 | Irrisept |
| Abbott Laboratories | $21.64 | 2022 | |
| Lilly USA, LLC | $17.41 | 2020 | |
| Medtronic, INC. | $15.82 | 2023 | Navlock |
| Pacira Pharmaceuticals Incorporated | $14.59 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Winston Fong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.